Novel organoid construction strategy for non-involuting congenital hemangioma for drug validation

[1]  Yi Ji,et al.  Three-Dimensional Microtumor Formation of Infantile Hemangioma-Derived Endothelial Cells for Mechanistic Exploration and Drug Screening , 2022, Pharmaceuticals.

[2]  Yun-Feng Zhang,et al.  Preterm neonate with a large congenital hemangioma on maxillofacial site causing thrombocytopenia and heart failure: A case report , 2022, World Journal of Clinical Cases.

[3]  Siyuan Chen,et al.  Infantile hepatic hemangiomas: looking backwards and forwards , 2022, Precision clinical medicine.

[4]  Siyuan Chen,et al.  Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial. , 2022, Blood.

[5]  M. Movassaghi,et al.  Pediatric Penile Non-Involuting Congenital Hemangioma with an Associated Pyogenic Granuloma: Surgical Management of a Rare Vascular Anomaly. , 2021, Urology.

[6]  D. Anselmo,et al.  Catastrophic congenital hemangioma with severe coagulopathy leading to fatal cardiac failure: Case report and review , 2021, Pediatric dermatology.

[7]  K. Nagel-Wolfrum,et al.  Human brain organoids assemble functionally integrated bilateral optic vesicles. , 2021, Cell stem cell.

[8]  E. Voest,et al.  Tumor organoids: Opportunities and challenges to guide precision medicine. , 2021, Cancer cell.

[9]  Yi Ji,et al.  A prospective multicenter study of sirolimus for complicated vascular anomalies. , 2021, Journal of vascular surgery.

[10]  H. Ezaldein,et al.  Impact of congenital cutaneous hemangiomas on newborn care in the United States , 2020, Archives of Dermatological Research.

[11]  B. Drolet,et al.  Infantile and congenital hemangiomas. , 2020, Seminars in pediatric surgery.

[12]  Graham M Lord,et al.  ILC1 drive intestinal epithelial and matrix remodelling , 2020, Nature Materials.

[13]  R. Xu,et al.  Tumor organoid models in precision medicine and investigating cancer-stromal interactions. , 2020, Pharmacology & therapeutics.

[14]  Y. Hsieh,et al.  Endothelial Cell-Specific Molecule 1 Promotes Endothelial to Mesenchymal Transition in Renal Fibrosis , 2020, Toxins.

[15]  J. López-Gutiérrez,et al.  Congenital hepatic hemangiomas: Clinical, histologic, and genetic correlation. , 2020, Journal of pediatric surgery.

[16]  C. Hua,et al.  A case series of Tardive Expansion Congenital Hemangioma: a Variation of NICH or a New Hemangiomatous Entity? , 2020, Journal of the American Academy of Dermatology.

[17]  D. Winter,et al.  Organoids - past learning and future perspectives. , 2019, Stem cells and development.

[18]  Ye Seul Son,et al.  Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. , 2019, Journal of hepatology.

[19]  Yan Li,et al.  Tumor organoids: From inception to future in cancer research. , 2019, Cancer letters.

[20]  M. Rafat,et al.  Growth and Characterization of Irradiated Organoids from Mammary Glands. , 2019, Journal of visualized experiments : JoVE.

[21]  A. van Oudenaarden,et al.  An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity , 2019, Nature Medicine.

[22]  Hans Clevers,et al.  A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. , 2018, Cell stem cell.

[23]  Matthias P Lutolf,et al.  Progress and potential in organoid research , 2018, Nature Reviews Genetics.

[24]  Hossein Baharvand,et al.  Personalized Cancer Medicine: An Organoid Approach. , 2018, Trends in biotechnology.

[25]  Atsushi Suzuki,et al.  Generation of Mouse and Human Organoid-Forming Intestinal Progenitor Cells by Direct Lineage Reprogramming. , 2017, Cell stem cell.

[26]  M. Vikkula,et al.  Vascular Anomalies Caused by Abnormal Signaling within Endothelial Cells: Targets for Novel Therapies , 2017, Seminars in Interventional Radiology.

[27]  Anita Gupta,et al.  Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis. , 2017, Pathology.

[28]  Dong Gao,et al.  The potential of organoids in urological cancer research , 2017, Nature Reviews Urology.

[29]  H. Clevers,et al.  Long-Term Adult Feline Liver Organoid Cultures for Disease Modeling of Hepatic Steatosis , 2017, Stem cell reports.

[30]  M. King,et al.  Possible toxicity following embolization of congenital giant vertex hemangioma: case report. , 2017, Journal of neurosurgery. Pediatrics.

[31]  W. Ingman,et al.  Human glandular organoid formation in murine engineering chambers after collagenase digestion and flow cytometry isolation of normal human breast tissue single cells , 2016, Cell biology international.

[32]  T. Crombleholme,et al.  Symptomatic Congenital Hemangioma and Congenital Hemangiomatosis Associated With a Somatic Activating Mutation in GNA11. , 2016, JAMA dermatology.

[33]  E. Sorantin,et al.  Sirolimus for the treatment of children with various complicated vascular anomalies , 2015, European Journal of Pediatrics.

[34]  F. Brunelle,et al.  Life-threatening hemorrhaging in neonatal ulcerated congenital hemangioma: two case reports. , 2015, JAMA dermatology.

[35]  C. Emery,et al.  Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations , 2014, Oncogene.

[36]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[37]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[38]  Alexander Kamb,et al.  What's wrong with our cancer models? , 2005, Nature Reviews Drug Discovery.

[39]  J. Mulliken,et al.  Congenital hemangiomas and infantile hemangioma: missing links. , 2004, Journal of the American Academy of Dermatology.

[40]  J. Mulliken,et al.  Noninvoluting Congenital Hemangioma: A Rare Cutaneous Vascular Anomaly , 2001, Plastic and reconstructive surgery.

[41]  J. Mulliken,et al.  Congenital hemangioma: evidence of accelerated involution. , 1996, The Journal of pediatrics.

[42]  J. Mulliken,et al.  Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. , 2016, American journal of human genetics.

[43]  J. Powell,et al.  Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. , 2014, Journal of the American Academy of Dermatology.